Literature DB >> 32489261

Organizational guidance for the care of patients with head-and-neck cancer in Ontario.

J Irish1, J Kim2, J Waldron3, A C Wei4, E Winquist5, J Yoo6, A Boasie3,7, M Brouwers8, E Meertens9, S McNair10, C Walker-Dilks10.   

Abstract

Background: At the request of the Head and Neck Cancers Advisory Committee of Ontario Health (Cancer Care Ontario), a working group and expert panel of clinicians with expertise in the management of head-and-neck cancer developed the present guideline. The purpose of the guideline is to provide advice about the organization and delivery of health care services for adult patients with head-and-neck cancer.
Methods: This document updates the recommendations published in the Ontario Health (Cancer Care Ontario) 2009 organizational guideline The Management of Head and Neck Cancer in Ontario. The guideline development methods included an updated literature search, internal review by content and methodology experts, and external review by relevant health care providers and potential users.
Results: To ensure that all patients have access to the highest standard of care available in Ontario, the guideline establishes the minimum requirements to maintain a head-and-neck disease site program. Recommendations are made about the membership of core and extended provider teams, minimum skill sets and experience of practitioners, cancer centre-specific and practitioner-specific volumes, multidisciplinary care requirements, and unique infrastructure demands. Conclusions: The recommendations contained in this document offer guidance for clinicians and institutions providing care for patients with head-and-neck cancer in Ontario, and for policymakers and other stakeholders involved in the delivery of health care services for head-and-neck cancer. 2020 Multimed Inc.

Entities:  

Keywords:  Ontario Health (Cancer Care Ontario); head-and-neck cancer; organizational guidelines

Mesh:

Year:  2020        PMID: 32489261      PMCID: PMC7253750          DOI: 10.3747/co.27.5873

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  2 in total

1.  Demographic and pathologic factor regression to a growth rate model of p16-negative oral cavity squamous cell carcinoma.

Authors:  Jacob G J Wihlidal; Keng Yeow Tay; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; John H J Yoo; Adrian I Mendez
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-16

2.  Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.

Authors:  Giovanni Pentangelo; Steven Paul Nisticò; Eugenio Provenzano; Giusy Ylenia Cisale; Luigi Bennardo
Journal:  Medicina (Kaunas)       Date:  2021-06-02       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.